Keyphrases
Human T-cell Leukemia Virus Type 1 (HTLV-1)
98%
Epstein-Barr Virus
96%
Measles Virus
72%
Tumor
70%
Virus
67%
Natural Killer Cells
63%
High-risk Human Papillomavirus (HR-HPV)
58%
T Cells
57%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
44%
Cotton Rat
41%
Head-and-neck Cancer
40%
Oncolytic Herpes Simplex Virus (oHSV)
36%
Head-and-neck
35%
Viral
31%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
30%
Oncolytic Virus
30%
Immune Response
29%
HPV16
25%
Glioblastoma
25%
Papillomavirus Infections
25%
Mouse Model
22%
Overall Survival
22%
Virus Type
22%
Oral Human Papillomavirus
22%
Tumor Cells
22%
Gene Expression
21%
Immune Function
21%
Cutaneous T-cell Lymphoma
20%
Protein Arginine Methyltransferase 5 (PRMT5)
20%
Nasopharyngeal Carcinoma
20%
Mantle Cell Lymphoma
20%
Adult T-cell Leukemia
19%
Oncolytic
19%
Older Adults
19%
Non-Hodgkin Lymphoma
19%
Virus Replication
18%
Lymphoma
18%
Measles Infection
18%
Inflammation
17%
Mycosis Fungoides
17%
Burkitt Lymphoma
17%
AIDS/HIV
17%
Chemotherapy
17%
Sigmodon Hispidus
17%
Interferon-α (IFN-α)
16%
Clinical Trials
16%
Confidence Interval
16%
Immune System
15%
Virus-specific
15%
Nucleoside Triphosphate Diphosphohydrolase
15%
Glioma
15%
Herpes Simplex Virus Type 1 (HSV-1)
15%
B Cells
15%
Interleukin-6
15%
Interleukin-2
15%
Virotherapy
14%
United States
14%
Lymphocytes
14%
Chronic Lymphocytic Leukemia
14%
Viral Replication
14%
Cellular Immune Response
14%
Infected Cells
13%
Risk Factors
13%
Respiratory Syncytial Virus
13%
In Cancer
13%
Malignancy
13%
Lymphoproliferative Disorders
13%
Apoptosis
13%
Antitumor Efficacy
13%
Cancer Cells
13%
Macrophages
13%
Chronic Stress
13%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
13%
Cytomegalovirus
13%
Antibody Titer
12%
Relapsed or Refractory
12%
Herpesvirus
12%
HTLV-2
12%
Stress-induced
12%
Psychological Stress
12%
Progression-free Survival
12%
Immune Dysregulation
12%
Retrovirus
12%
CD8+ T Cells
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Hybrid Cells
11%
NF-B
11%
Lymphoma Cells
11%
Phosphorylation
11%
T Cell Response
11%
Recombinant
11%
Rituximab
11%
Virus Genome
11%
Psychoneuroimmunology
11%
Overexpression
11%
Neutralizing Antibodies
11%
Tumor Microenvironment
11%
MicroRNA
11%
Heat Shock Protein 70 (HSP70)
11%
Quantitative PCR
11%
Immunology and Microbiology
T Cell
100%
Epstein Barr Virus
89%
Measles Virus
72%
Human T-Lymphotropic Virus 1
69%
Natural Killer Cell
66%
Immunity
52%
Viral Disease
48%
Cotton Rat
40%
Immune Response
33%
B Cell
29%
Wart Virus
28%
Immunology
27%
Viral Replication
26%
Human T Cell Leukemia Virus
26%
Human Immunodeficiency Virus
25%
Cytokine
24%
Gene Expression
24%
Cell Line
23%
Squamous Cell
22%
Virus Type
22%
interferon
21%
Lymphocyte
20%
Human T-Lymphotropic Virus 2
20%
Promoter Region
20%
Oncolytic Virus
20%
Oncolytic Herpes Virus
20%
Tumor Cell
19%
Virotherapy
18%
Interleukin 2
18%
Mouse Model
18%
Herpesviridae
18%
Immune System
17%
Immunotherapy
17%
Macrophage
16%
Wild Type
16%
DNA Virus
15%
T-Helper Cell
15%
Neck
15%
Human Respiratory Syncytial Virus
15%
Cytotoxic T-Cell
15%
Human Alphaherpesvirus 1
14%
Retrovirus
14%
Cytotoxicity
14%
Adoptive Immunity
14%
Glycoprotein
14%
Lymphoma Cell
13%
Cytomegalovirus
13%
Cancer Cell
13%
Antibody Titer
12%
Virus Genome
12%
Heat Shock
12%
Encephalitis
12%
Innate Immune System
11%
Human Papillomavirus Type 16
11%
Virus
11%
Psychoneuroimmunology
11%
Prevalence
11%
Virus Nucleocapsid
11%
Leukocyte
10%
Xenograft
10%
Cytotoxic T Cell
10%
Spumavirus
10%
Mental Stress
10%
Carboxy Terminal Sequence
10%
Neutralizing Antibody
10%
Cell Transformation
9%
Immunocompetent Cell
9%
Central Nervous System
9%
Signal Transduction
9%
Transcription Factors
9%
Cellular Stress Response
9%
Myeloid
9%
Maternal Antibody
9%
Hybrid Cell
8%
Interleukin 6
8%
Secretion (Process)
8%
Canine Distemper Virus
8%
Early Antigen
8%
Proinflammatory Cytokine
8%
Vesiculovirus
8%
Monoclonal Antibody
8%
Adaptive Immune System
8%
Cell Function
8%
Peripheral Blood Mononuclear Cell
8%
Multiple Myeloma
8%
Immune Dysregulation
8%
Dendritic Cell
8%
Integrase
7%
Leporidae
7%
Interleukin 15
7%
Human Cytomegalovirus
7%
Lymphoproliferative Disorders
7%
Downregulation
7%
Tumor Necrosis Factor
7%
Cell Maturation
7%
Titer
7%
Immunosuppression
7%
Minimum Inhibitory Concentration
7%
Human Immunodeficiency Virus 1
7%
Methylation
7%
Medicine and Dentistry
Neoplasm
87%
Malignant Neoplasm
69%
Wart Virus
55%
Disease
50%
Epstein Barr Virus
42%
Head and Neck Cancer
37%
T Cell
35%
Infection
33%
Neck
31%
Human Immunodeficiency Virus
28%
Overall Survival
26%
In Vitro
26%
Oropharynx Carcinoma
25%
Human T-Lymphotropic Virus 1
23%
Immunity
23%
Free Tissue Graft
22%
Cancer
21%
Non-Hodgkin Lymphoma
21%
Oncolytic Herpes Virus
21%
Papillomavirus Infection
21%
Head and Neck Squamous Cell Carcinoma
21%
Glioblastoma
19%
B Cell
19%
Ganglioglioma
19%
Radiation Therapy
19%
Oncolytic Virus
18%
Clinical Trial
18%
Chemotherapy
18%
Tumor Cell
17%
Squamous Cell Carcinoma
17%
Human Papillomavirus Type 16
17%
Natural Killer Cell
16%
Immunotherapy
16%
Cutaneous T Cell Lymphoma
16%
Oncology
15%
Oropharynx Squamous Cell Carcinoma
15%
Cancer Cell
14%
Xenograft
14%
Mantle Cell Lymphoma
14%
Mycosis fungoides
14%
Adult T-Cell Leukemia/Lymphoma
13%
Progression Free Survival
13%
Receptor
12%
Malignant Peripheral Nerve Sheath Tumor
12%
Lymphoproliferative Disease
12%
Surgery
12%
Immune Response
12%
Oral Cavity
12%
Lymphocyte
12%
Cell Line
11%
Oncolytic Virotherapy
11%
T-Cell Lymphoma
11%
B-Cell Lymphoma
11%
P16
11%
Pediatrics
11%
Carcinogenesis
11%
Prevalence
11%
Programmed Cell Death
10%
Oropharynx
10%
Nasopharynx Carcinoma
10%
Diffuse Large B-Cell Lymphoma
10%
Gene Expression
10%
Tumor Progression
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Burkitt's Lymphoma
10%
Robot-Assisted Surgery
9%
Biological Marker
9%
Human Alphaherpesvirus 1
9%
Virus Infection
9%
Messenger RNA
9%
Recurrent Disease
9%
Hazard Ratio
9%
Cytotoxicity
8%
Protein Arginine Methyltransferase 5
8%
Cytokine
8%
Cancer Therapy
8%
Metastatic Carcinoma
8%
Macrophage
8%
Rituximab
8%
Combination Therapy
8%
Pediatric Cancer
8%
Nivolumab
8%
Virotherapy
8%
Diagnosis
8%
Oral Cancer
7%
Cytotoxic T-Cell
7%
Transplantation
7%
Cytomegalovirus
7%
Base
7%
Solid Malignant Neoplasm
7%
Leukemia
7%
Virus DNA
7%
Virus Replication
7%
Cohort Effect
7%
Rhabdomyosarcoma
7%
Quality of Life
7%
Intracranial Tumor
7%
Endothelial Cell
6%
Serositis
6%
Virus Genome
6%